Pseudohypoparathyroidism type I A: genes and variants
Explore variant evidence for Pseudohypoparathyroidism type I A across 1 analyzed protein (GNAS). Linked ClinVar records include 29 pathogenic or likely pathogenic variants, 6 variants of uncertain significance and 7 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-15. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Pseudohypoparathyroidism type I A
GNAS: Guanine nucleotide-binding protein G(s) subunit alpha isoforms short
It produces the stimulatory G-alpha subunit that activates adenylyl cyclase downstream of many hormone receptors, with complex tissue-specific imprinting at the locus. Inactivating variants cause pseudohypoparathyroidism-spectrum disorders, while activating somatic variants cause McCune-Albright syndrome and some endocrine tumors.
29 ClinVar pathogenic / likely pathogenic and 13 uncertain variants in GNAS have source records linked to Pseudohypoparathyroidism type I A. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Pseudohypoparathyroidism type I A
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| GNAS R201H | 201 | G-alpha | Pathogenic / likely pathogenic (★★) |
| GNAS R231H | 231 | G-alpha | Pathogenic / likely pathogenic (★★) |
| GNAS R265H | 265 | G-alpha | Pathogenic / likely pathogenic (★★) |
| GNAS R165C | 165 | G-alpha | Pathogenic / likely pathogenic (★★) |
| GNAS R232H | 232 | G-alpha | Pathogenic / likely pathogenic (★★) |
| GNAS I103T | 103 | G-alpha | Pathogenic / likely pathogenic (★★) |
| GNAS R228C | 228 | G-alpha | Pathogenic / likely pathogenic (★★) |
| GNAS R265C | 265 | G-alpha | Pathogenic / likely pathogenic (★★) |
| GNAS R336W | 336 | G-alpha | Pathogenic / likely pathogenic (★★) |
| GNAS G353R | 353 | G-alpha | Pathogenic / likely pathogenic (★★) |
| GNAS E392K | 392 | G-alpha | Pathogenic / likely pathogenic (★★) |
| GNAS R199C | 199 | G-alpha | Pathogenic / likely pathogenic (★) |
| GNAS R199P | 199 | G-alpha | Pathogenic / likely pathogenic (★) |
| GNAS R199L | 199 | G-alpha | Pathogenic / likely pathogenic (★) |
| GNAS R258L | 258 | G-alpha | Pathogenic / likely pathogenic (★) |
| GNAS R42S | 42 | G-alpha | Pathogenic / likely pathogenic (★) |
| GNAS G52S | 52 | G-alpha | Pathogenic / likely pathogenic (★) |
| GNAS L282R | 282 | G-alpha | Pathogenic / likely pathogenic (★) |
| GNAS S306L | 306 | G-alpha | Pathogenic / likely pathogenic (★) |
| GNAS R342Q | 342 | G-alpha | Pathogenic / likely pathogenic (★) |
| GNAS R356H | 356 | G-alpha | Pathogenic / likely pathogenic (★) |
| GNAS I372T | 372 | G-alpha | Pathogenic / likely pathogenic (★) |
| GNAS Q384E | 384 | G-alpha | Pathogenic / likely pathogenic (★) |
| GNAS M1I | 1 | Pathogenic / likely pathogenic (★) | |
| GNAS L43V | 43 | G-alpha | Pathogenic / likely pathogenic (★) |
| GNAS R160G | 160 | G-alpha | Pathogenic / likely pathogenic (★) |
| GNAS K293R | 293 | G-alpha | Pathogenic / likely pathogenic (★) |
| GNAS R258P | 258 | G-alpha | Pathogenic / likely pathogenic (★) |
| GNAS R347T | 347 | G-alpha | Pathogenic / likely pathogenic (★) |
Uncertain variants prioritized for review in Pseudohypoparathyroidism type I A
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| GNAS R228H | 228 | G-alpha | Uncertain (★★) | +7: 2 other pathogenic changes within 3 positions; R228C at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.803 |
Same protein, different disease
- Pseudohypoparathyroidism also has ClinVar records linked to GNAS variants; they fall partly in the same places as the Pseudohypoparathyroidism type I A variants (13 pathogenic / likely pathogenic).
- Pseudopseudohypoparathyroidism also has ClinVar records linked to GNAS variants; they fall partly in the same places as the Pseudohypoparathyroidism type I A variants (7 pathogenic / likely pathogenic).
- McCune-Albright syndrome also has ClinVar records linked to GNAS variants; they fall in the same places as the Pseudohypoparathyroidism type I A variants (5 pathogenic / likely pathogenic).
Diseases related to Pseudohypoparathyroidism type I A
- Hereditary spastic paraplegia, also linked to GNAS
- Pseudohypoparathyroidism, also linked to GNAS
- Pseudopseudohypoparathyroidism, also linked to GNAS
- McCune-Albright syndrome, also linked to GNAS
- Pituitary adenoma 3, multiple types, also linked to GNAS
Frequently asked questions
Which genes have records linked to Pseudohypoparathyroidism type I A?
This view contains 1 analyzed proteins: GNAS. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 29 pathogenic or likely pathogenic variants, 6 variants of uncertain significance and 7 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 42 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center